Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases

• Status: Not yet recruiting
• Trial end date: 2023-04-15
• Target enrollment: 0
• Participant gender: Female

Summary

In our study, it was aimed to show the contribution of intraoperative intravenous magnesium sulfate administration to peroperative opioid consumption and postoperative analgesia.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ondokuz Mayıs University
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Patient undergoing abdominal hysterectomy

• Between the ages of 20-70,

• ASA I- II

Exclusion Criteria:

• Presence of hepatic and renal dysfunction,

• Presence of cardiac arrhythmia or other cardiac comorbidity,

• Neurological and psychiatric disorder,

• Chronic use of calcium and beta blockers,

• Drug or alcohol abuse,

• Pregnancy and lactation status,

• Patients with a history of allergy to any drug included in the study protocol